720
Participants
Start Date
February 14, 2018
Primary Completion Date
September 26, 2019
Study Completion Date
September 26, 2019
AS03
Oil-in-water emulsion based adjuvant system.
Inactivated influenza H7N9 vaccine
Monovalent 2017 H7N9 inactivated influenza vaccine
Phosphate Buffered Saline (PBS) diluent
Diluent for 2017 Monovalent Inactivated Influenza A/H7N9 virus vaccine (2017 H7N9 IIV)
Duke Vaccine and Trials Unit, Durham
The Hope Clinic of Emory University, Decatur
University of Iowa - Vaccine Research and Education Unit, Iowa City
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore
Kaiser Permanente Washington Health Research Institute, Seattle
National Institute of Allergy and Infectious Diseases (NIAID)
NIH